Filtered By:
Vaccination: Cancer Vaccines
This page shows you your search results in order of relevance. This is page number 10.
Order by Relevance | Date
Total 479 results found since Jan 2013.
Evaluation of Safety and Side Effects COVID-19 Vaccine in Cancer Patients Being Treated
Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1263-1270. doi: 10.31557/APJCP.2022.23.4.1263.ABSTRACTAccording to the instructions of Iran's National Corona Response Committee in the Iranian Ministry of Health and Medical Education, patients undergoing treatments for their cancer are prioritized in Covid-19 vaccination. The present study was therefore conducted to investigate the toxicity and acute side-effects of a Covid-19 vaccine in cancer patients presenting to Medical Oncology Clinic of Kermanshah University of Medical Science. After excluding the patients with active infection and the recently-infected ones with Covid-19,...
Source: Asian Pacific Journal of Cancer Prevention - April 29, 2022 Category: Cancer & Oncology Authors: Mozaffar Aznab Maryam Chalehchaleh Somayeh Dokoshkani Maryam Rezaei Source Type: research
New Data Show TREMFYA ® (guselkumab) Binds to Both Inflammatory Cells and Interleukin (IL)-23, Supporting a Hypothesis for a Differentiated Mechanism from Risankizumab
SPRING HOUSE, PENNSYLVANIA, May 18, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the first results of the in vitro MODIF-Y studies, supporting a hypothesis that may differentiate the mechanism of first-in-class TREMFYA® (guselkumab) from risankizumab due to the ability of TREMFYA to bind to CD64 positive (CD64+) cells in addition to interleukin (IL)-23 — both of which are key components of the immune system. 1,2 These findings, which are being presented at the Society for Investigative Dermatology (SID) annual meeting May 18-21, 2022 in Portland, Oregon, demonstrate TREMFYA bind...
Source: Johnson and Johnson - May 18, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Evaluation of Safety and Side Effects COVID-19 Vaccine in Cancer Patients Being Treated
Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1263-1270. doi: 10.31557/APJCP.2022.23.4.1263.ABSTRACTAccording to the instructions of Iran's National Corona Response Committee in the Iranian Ministry of Health and Medical Education, patients undergoing treatments for their cancer are prioritized in Covid-19 vaccination. The present study was therefore conducted to investigate the toxicity and acute side-effects of a Covid-19 vaccine in cancer patients presenting to Medical Oncology Clinic of Kermanshah University of Medical Science. After excluding the patients with active infection and the recently-infected ones with Covid-19,...
Source: Asian Pacific Journal of Cancer Prevention - April 29, 2022 Category: Cancer & Oncology Authors: Mozaffar Aznab Maryam Chalehchaleh Somayeh Dokoshkani Maryam Rezaei Source Type: research
